DPP4inhibitors in Type 1 Diabetes
NCT01922817
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Hypoglycaemia
Interventions
DRUG:
Saxagliptin
Sponsor
University of Dundee